| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Hospital & Healthcare Services
|
Compare with Industry peers |
| Website | http://www.lotuseye.org | |
| Market Cap | 145.57 Cr. | |
| Enterprise Value(EV) | 135.46 Cr. | 2022-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 2.02 | Trailing Twelve Months Ending 2022-09 |
| Price-Earning Ratio (PE) | 34.69 | Trailing Twelve Months Ending 2022-09 |
| Industry PE | 45.92 | Trailing Twelve Months Ending 2022-09 |
| Book Value / Share | 26.86 | Trailing Twelve Months Ending 2022-09 |
| Price to Book Value | 2.61 | Calculated using Price: 70.00 |
| Dividend Yield | 0.71 | Period Ending 2022-03 |
| No. of Shares Subscribed | 2.08 Cr. | 20,796,330 Shares |
| FaceValue | 10 | |
| Company Profile | ||
| Lotus Eye Care Hospital was originally incorporated as ‘Kalaivani Health Centre Pvt. Ltd.'on March 14,1997 under the Companies Act, 1956 vide Certificate of Incorporation issued by the Registrar of Companies, Tamil Nadu, Coimbatore. The name of the Company was changed to ‘Lotus Eye Care Hospital Pvt. Ltd. on January 23, 2006 and subsequently to ‘Lotus Eye Care Hospital Limited' upon conversion into Public Limited Company on October 16, 2007 and a fresh certificate of incorporation has been obtained from Registrar of Companies, Tamil Nadu, Coimbatore. | ||
| 1 Day |
|
-1.41% |
| 1 Week |
|
-1.48% |
| 1 Month |
|
-15.56% |
| 3 Month |
|
+1.89% |
| 6 Month |
|
-0.99% |
| 1 Year |
|
+0.50% |
| 2 Year |
|
+99.71% |
| 5 Year |
|
+131.02% |
| 10 Year |
|
+771.73% |
| 9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
| Return on Equity (%) | 0.08 | -3.93 | 0.20 | 0.89 | 3.47 | 1.41 | 2.10 | 3.02 | 5.56 | |
| Return on Capital Employed (%) | 0.27 | -4.14 | 0.27 | 1.13 | 3.71 | 1.66 | 3.32 | 4.07 | 8.00 | |
| Return on Assets (%) | 0.07 | -3.45 | 0.18 | 0.81 | 3.12 | 1.25 | 1.89 | 2.71 | 4.99 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
| Shh. Funds | 51 | 49 | 49 | 50 | 51 | 50 | 51 | 53 | 55 | 56 | |
| Non Curr. Liab. | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | |
| Curr. Liab. | 7 | 6 | 5 | 4 | 7 | 6 | 6 | 6 | 6 | 7 | |
| Minority Int. | |||||||||||
| Equity & Liab. | 59 | 56 | 55 | 55 | 57 | 56 | 57 | 58 | 61 | 64 | |
| Non Curr. Assets | 52 | 51 | 48 | 48 | 49 | 49 | 47 | 45 | 48 | 48 | |
| Curr. Assets | 7 | 5 | 6 | 7 | 8 | 7 | 11 | 14 | 13 | 15 | |
| Misc. Exp. not W/O | |||||||||||
| Total Assets | 59 | 56 | 55 | 55 | 57 | 56 | 57 | 58 | 61 | 64 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09 Rs. Cr. TTM |
| Net Sales | 29 | 30 | 31 | 34 | 38 | 38 | 41 | 32 | 39 | 46 | |
| Other Income | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| Total Income | 29 | 30 | 32 | 35 | 39 | 39 | 41 | 33 | 40 | 47 | |
| Total Expenditure | -26 | -29 | -28 | -31 | -34 | -35 | -37 | -29 | -33 | -38 | |
| PBIDT | 3 | 2 | 4 | 4 | 5 | 4 | 5 | 4 | 7 | 9 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Depreciation | -3 | -4 | -4 | -3 | -3 | -3 | -3 | -2 | -3 | -3 | |
| Taxation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | -2 | |
| Exceptional Items | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | |||
| PAT | 0 | -2 | 0 | 0 | 2 | 1 | 1 | 2 | 3 | 4 | |
| Adjusted EPS | 0 | -1 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 2 |
| Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Cash Fr. Operatn. | 4 | 4 | 2 | 3 | 3 | 6 | 4 | 5 | 3 | 4 | |
| Cash Fr. Inv. | -1 | -5 | -5 | -1 | -1 | -4 | -4 | -1 | 0 | -4 | |
| Cash Fr. Finan. | 0 | -1 | 2 | -1 | 0 | -2 | -1 | 0 | 0 | -2 | |
| Net Change | 2 | -1 | 0 | 2 | 2 | 0 | -1 | 4 | 3 | -1 | |
| Cash & Cash Eqvt | 2 | 1 | 1 | 2 | 3 | 4 | 3 | 7 | 10 | 9 |
|
Fri, 27 Jan 2023
Board Meeting Intimation for Intimation Of Board Meeting Lotus Eye Hospital And Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 inter alia to consider and approve Pursuant to Regulation 29 and other applicable provisions of the SEBI (LODR) Regulations 2015 we wish to inform you that the Board of Directors of the company will be meeting on Monday February 13 2023 inter-alia to consider the following: -1. Unaudited Standalone Financial Results of the company for the quarter and year ended December 31 2022.Further with reference to our earlier intimation December 31 2022 we wish to inform that in accordance with SEBI (Prohibition of Insider Trading) Regulations 2015 and the Code of Conduct for Insiders of the Company the trading window will re-open from February 16 2023 onwards.Request you to kindly take the same on your record. |
|
Sat, 07 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Based on the confirmation received from S.K.D.C. Consultants Limited Registrar and Transfer Agent of the company we hereby certify that the securities received for dematerialization have been mutilated and cancelled after due verification and the name of the depository has been substituted in our records as the registered owner within 15 days of receipt of certificate of security and the details are furnished to the stock exchanges.Further we certify that the securities which were dematerialized are listed on the Stock Exchanges where the earlier issued securities are listed..We request you to take this information on record. |
|
Sat, 31 Dec 2022
Closure of Trading Window This is to inform you that as per the SEBI (Prohibition of Insider trading ) regulations 2015 read with BSE Circular Ref No LIST/COMP/01/2019-20 and as per the terms of Code of Internal Procedures and conduct for regulating Monitoring and Reporting of Trading by Insiders of the company the trading window for dealing in the Company shares will remain closed from January 1st 2023 till the end of 48 hours after declaration of audited financial results for the quarter ending on 31st December 2022 for specified designated persons as defined in the code. The same has been informed to the Directors and designated persons of the Company.The date of Board Meeting for declaration of the financial results of the Company for the quarter ended December 31st 2022 will be intimated in the due course. |
| Fri, 03 Feb 2023 |
Close Crossing Last Month Close from Above
|
Opening at Low
|
Close Below Last Week Low
|
High Decrease in 1 Month
|
High Increase in 2 Years
|
Equities
M.F.
Sectors